Owens & Minor (OMI) Expected to Announce Quarterly Earnings on Friday

Owens & Minor (NYSE:OMI) is anticipated to issue its quarterly earnings data before the market opens on Friday, February 28th. Analysts expect the company to announce earnings of $0.53 per share and revenue of $2.68 billion for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

Owens & Minor Trading Down 3.0 %

OMI stock opened at $6.84 on Thursday. The firm has a fifty day moving average price of $11.68 and a 200 day moving average price of $13.35. Owens & Minor has a fifty-two week low of $6.07 and a fifty-two week high of $28.35. The company has a debt-to-equity ratio of 2.11, a quick ratio of 0.45 and a current ratio of 1.09. The firm has a market cap of $527.04 million, a PE ratio of -10.52, a price-to-earnings-growth ratio of 0.20 and a beta of 0.48.

Analyst Ratings Changes

OMI has been the subject of a number of recent research reports. UBS Group cut their target price on shares of Owens & Minor from $25.00 to $13.00 and set a “buy” rating for the company in a report on Thursday, February 13th. Citigroup cut their price objective on shares of Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Barclays cut their price objective on shares of Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Finally, Robert W. Baird cut their price objective on shares of Owens & Minor from $14.00 to $10.00 and set a “neutral” rating on the stock in a research report on Tuesday. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, Owens & Minor has a consensus rating of “Hold” and an average target price of $14.92.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.